Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the act and are set out in the Schedule hereto: Schedule Product: Melodene 28. Active Ingredient(s): Gestodene 0.075 mg. Ethinyloestradiol 0.02 mg. Dosage Form: Tablet. NZ Sponsor: Schering (NZ) Limited. Manufacturer(s): Schering AG, Wedding Plant, Berlin, Germany. Schering SA, Zone Industrial de Roubaix-Est, Lys Lez Lannoy, France. Dated this 25th day of November 1999. S. S. JESSAMINE, Acting Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).